PS Ratio:
N/ASummary
- BPMC price to sales ratio is not available.
Performance
BPMC PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
BPMC PS Ratio Trends
| PeriodPeriod | PS RatioPS Ratio | PricePrice | Market CapMarket Cap | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | - | - | - | +10.5% |
| 3M3 Months | - | - | - | +10.5% |
| 6M6 Months | - | - | - | - |
| 1Y1 Year | - | - | - | +99.2% |
| 5Y5 Years | - | - | - | -30.7% |
BPMC PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | ||||
| 3M | 3-Month | 14.87 | 14.87 | ||
| 6M | 6-Month | 14.87 | 9.58 | ||
| 1Y | 1-Year | 14.87 | 9.10 | ||
| 3Y | 3-Year | 26.10 | 9.02 | ||
| 5Y | 5-Year | 63.68 | 5.73 | ||
| All-Time | All-Time | 1493.62 | 5.73 |
BPMC PS Ratio History
| Date | Value |
|---|---|
| 2024 | 10.92(-51.7%) |
| 2023 | 22.62(+75.8%) |
| 2022 | 12.87(-63.4%) |
| 2021 | 35.18(+330.6%) |
| Date | Value |
|---|---|
| 2020 | 8.17(-86.2%) |
| 2019 | 59.35(+11.3%) |
| 2018 | 53.32(-65.2%) |
| 2017 | 153.37(+358.5%) |
| 2016 | 33.45 |
FAQ
- What is the all-time high PS ratio for Blueprint Medicines Corporation?
What is the all-time high PS ratio for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high price to sales ratio is 1493.62